174 related articles for article (PubMed ID: 5054127)
1. [Diabetes-myxedema].
Trujillo Rodríguez F; Palma Alvarez A
Rev Iber Endocrinol; 1972; 19(112):361-9. PubMed ID: 5054127
[No Abstract] [Full Text] [Related]
2. Diabetes mellitus treated with chlorpropamide and tolbutamide. A four-year clinical study.
Powell T; Howells L
Diabetes; 1966 Apr; 15(4):269-75. PubMed ID: 5929542
[No Abstract] [Full Text] [Related]
3. [Chlorpropamide and other oral hypoglycemic agents in the treatment of diabetes mellitus resistant to tolbutamide. Clinico-statistical study].
Danelon-Martina L
Clin Ter; 1969 Apr; 49(2):135-46. PubMed ID: 5407314
[No Abstract] [Full Text] [Related]
4. [Diabetes and primary myxedema. 2 anatomo-clinical cases].
Codaccioni JL; Lebreuil G; Kleisbauer JP
Diabete; 1968; 16(2):109-12. PubMed ID: 5759094
[No Abstract] [Full Text] [Related]
5. [Glibenclamide in the treatment of diabetes].
Rojszykowa E
Pol Tyg Lek; 1971 Jan; 26(4):149-52. PubMed ID: 5547508
[No Abstract] [Full Text] [Related]
6. Thyroid-blocking activity of chlorpropamide in a diabetic patient with hyperthyroidism.
Tsou JY; Kotler M; Lavine RL
Arch Intern Med; 1981 Apr; 141(5):690-1. PubMed ID: 7224756
[No Abstract] [Full Text] [Related]
7. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
Herman JB
Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
[No Abstract] [Full Text] [Related]
8. Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
Fidel J; Nelken L
Isr J Med Sci; 1974 Jul; 10(7):702-6. PubMed ID: 4852026
[No Abstract] [Full Text] [Related]
9. Status of problem of usage of tolbutamide. Preliminary statements.
Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
[No Abstract] [Full Text] [Related]
10. Blood sugar lowering effects of chlorpropamide and tolbutamide. A double blind cooperative study.
Katz HM; Bissel G
Diabetes; 1965 Oct; 14(10):650-7. PubMed ID: 5318832
[No Abstract] [Full Text] [Related]
11. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
12. [On the oral therapy of diabetes with oradian and chlorpropamide].
Kaeding A; Werner P
Dtsch Z Verdau Stoffwechselkr; 1967 Dec; 27(5):185-90. PubMed ID: 5595738
[No Abstract] [Full Text] [Related]
13. Diabetes mellitus and primary hypothyroidism.
Ganz K; Kozak GP
Arch Intern Med; 1974 Sep; 134(3):430-2. PubMed ID: 4851354
[No Abstract] [Full Text] [Related]
14. Hyponatremia due to sulfonylurea compounds.
Hagen GA; Frawley TF
J Clin Endocrinol Metab; 1970 Nov; 31(5):570-6. PubMed ID: 5470213
[No Abstract] [Full Text] [Related]
15. [Diabetes mellitus therapy by sulfonylurea drugs].
Canaani Z
Dapim Refuiim; 1969 Jan; 28(1):59-64. PubMed ID: 5356314
[No Abstract] [Full Text] [Related]
16. [Treatment of diabetes mellitus with metformin].
Parrow A
Lakartidningen; 1968 Nov; 65(47):4671-6 passim. PubMed ID: 5742151
[No Abstract] [Full Text] [Related]
17. [On the simultaneous occurrence of diabetes mellitus and myxedema].
Hadnagy C
Z Arztl Fortbild (Jena); 1969 May; 63(9):511-3. PubMed ID: 5803099
[No Abstract] [Full Text] [Related]
18. [The myxedema-diabetes association].
Rodríquez Cuartero A; Morata García F
Rev Clin Esp; 1974 Mar; 132(5):445-50. PubMed ID: 4831275
[No Abstract] [Full Text] [Related]
19. [Dynamics of blood serum lipid and lipoprotein indices in diabetes mellitus, treated with chlorpropamide and butamide].
Sil'nitskiĭ PA
Probl Endokrinol (Mosk); 1968; 14(3):9-13. PubMed ID: 5734589
[No Abstract] [Full Text] [Related]
20. Chlorpropamide- and tolbutamide-alcohol flushing in non-insulin-dependent diabetes.
Capretti L; Speroni G; Girone M; Coscelli C; Butturini U; Rocca G
Br Med J (Clin Res Ed); 1981 Nov; 283(6303):1361-2. PubMed ID: 6797541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
